Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the sale of Quidel’s RapidVue hCG test, a lateral
Continue reading here:
Quidel Announces FDA Clearance Of Its RapidVue(R) HCG Pregnancy Lateral Flow Diagnostic Test
{ 0 comments }